Program in Detail

Program in Detail

1 August 2016
Time HALL A HALL B
8:00 9:00 Oral presentation Oral presentation
9:00 10:30 Transplantation: Chairman: Nasri- IrajNajafi Nursing Work shop (Meditechsys)
9:00 9:30 Predictors of allograft function: Ahmadpoor, IRAN
9:30 9:50 AMR, Diagnosis and potential therapies: Rostaing, FRANCE Membranes and its effect on dialysis adequacy
9:50 10:10 An overview of HLA antibody detection technics and donor specific antibody significance: Malvezzi, ITALY
10:10 10:30 Critical role of HLA typing and immunomonitoring in successful transplantation:. Kermani, USA
10:30 10:50 Break
10:50 13:00 Opening ceremony- Chairman: Nafar, Ahmadpoor  
10:50 11:35 Where do we stand in 2016? Rostaing, France  
11:35 13:00 OPENING CEREMONY  
13:00 14:00 Prayer and Lunch
14:00 14:30 Plenary  
Tolerance in kidneytransplantation: Nikooinejad IRAN Chairman: Ardalan,Mojahedi  
14:30 16:00 Review of dialysis guidelines: Chairman:Tayebi,Khosroshahi, Tabkhi Vesicoureteral Reflux (V.U.R) Chairman: Ghohestani, Ghadian
14:30 14:50 Fluids and electrolytes: Moradian, IRAN Diagnostic tools and Challenges: Dr. Arash Abbasi
14:50 15:10 Acid-base disorders in dialysis patients: Vahedian, IRAN Decision making for management: Dr. Amir Hassan Mahboubi
15:10 15:30 Dialysis adequacy: Tayebi, IRAN Surgical techniques Dr.Mohammad Ghohestani
15:30 15:50 Hemodialysis Membranes: Tabkhi, IRAN Case discussion and debate
15:50 16:00 Discussion  
16:00 16:20 Break
16:20 18:00 Review of dialysis guidelines: Chairman: Sanadghol, Nemati Research work shop
16:20 16:40 Hypotension: Soliemani, IRAN Online Medical Databases
16:40 17:00 Bone metabolism disorders: Nemati, IRAN
17:00 17:30 Hypertension: Ghadiani, IRAN
17:30 17:50 Antibiotic dosing in dialysis patients: Panahi, IRAN
17:50 18:00 Discussion
2 August 2016
Time HALL A HALL B
8:00 9:00 Oral presentation: Chairman: Makhloogh, Gholiof Oral presentation Chairman: Tayebi, Nehrir
9:00 10:30 Glomerular disease- Chairman: Argani-Savaj Nursing Work shop (Meditechsys)
9:00 9:30 Podocyte Biology and clinical applications: Ahmadi, IRAN
9:30 9:50 Update on treatment of Diabetic Nephropathy: Argani, IRAN The effect of Qualitative indicators Medical supplies on Quality dialysis treatment
9:50 10:10 Update on treatment of ANCA associated GN: Samadian, IRAN
10:10 10:30 Update on treatment of Membranous nephropathy: Pourrezagholi, IRAN
10:30 11:00 Break
11:00 11:30 Plenary: Chairman: Lessan-pezeshki- Ghods  
Spanish model of kidney transplantation: Campistol SPAIN  
11:30 13:00 Transplantation- Chairman: Khatami- Ahmadpoor Nursing Work shop (ATF)
11:30 12:00 mTOR Inhibitors in clinical practice: Campistol, SPAIN New Dialysis Devices
12:00 12:30 mTOR inhibitors and post-transplant viral diseases: Rostaing, FRANCE
12:30 13:00 mTOR inhibitors and cardiovascular and neoplastic issues: Malvezzi, ITALY
13:00 14:00 Prayer and Lunch
14:00 14:30 Plenary: Chairman: Hekmat, Ghafari  
Genetics in Nephrology: Dr.Saeid Morovvati  
14:30 16:00 Renal replacement therapy in elderly patients: Chairman: Momeni, Pourfarziani Renovascular hypertension Chairman: Ghadian, Asadi
14:30 14:50 Dialysis in Azerbaijan Epidemiology and Clinical characteristics: Dr. Mehdi Azarabadi
14:50 15:10 The time of initiation of dialysis: Chairman: Dr. Einollahi Screening for Renovascular Disease: Dr. Mousa Asadi
15:10 15:30 Kidney transplantation: Dr. Pourfarziani Diagnostic approach: Dr. Ramezan Jafari
15:30 15:50 Vascular access: Ahmadian Medical therapy: Dr. Mohammad Nikpour
15:50 16:00 Discussion Angioplasty and Stenting: Dr. Mohsen Sadeghi Ghahrodi
16:00 16:20 Break
16:20 18:00 Dialysis in special settings- Chairman: Einollahi-Afshar Research work shop
16:20 16:40 Pregnancy in women on dialysis: Nehrir, IRAN+ Social Media in Medical Research
16:40 17:00 Children: Beiraghdar, IRAN
17:00 17:30 ICU patients: Afshar, IRAN
17:30 17:50 AKI: Einollahi, IRAN
17:50 18:00 Discussion
3 August 2016
Time HALL A HALL B
8:00 9:00 Oral presentation: Chairman: Mosavi Beladi, Monfared Oral presentation Chairman: Tayebi, Tabkhi
9:00 10:30 CKD- Chairman: Abdi, Ghetmiri Nursing Work shop (SOHA)
9:00 9:30 CKD and hepatitis C: Mohamed Hani Hafez, Egypt
9:30 9:50 New roles of Intervention in nephrology: Dallili, IRAN

Dialysis Profiling

Blood Temperature Monitoring (BTM) Blood Volume Monitoring (BVM)

9:50 10:10 Hemodialysis adequacy; KT/V and beyond: Najafi, IRAN
10:10 10:30 Conservative management vs. dialysis in the elderly patient with stage 5 CKD: Abasi, IRAN
10:30 11:00 Break
11:00 1130 Plenary – Chairman: Argani, Atapoor  
CKD/MBD: Mohamed Hani Hafez, Egypt  
11:30 13:00 AKI- Chairman: Atabak, Rahbar Nursing Work shop (SOHA)
11:30 12:00 Update on pathogenesis of AKI: Sabaghian, IRAN

-Online clearance monitoring (OCM)

-Hemodiafilteration (HDF)  

12:00 12:30 Risk prediction models of AKI: Haghverdi, IRAN
12:30 13:00 Management of Cardio renal syndrome: Tabiban, IRAN
13:00 14:00 Prayer and Lunch
14:00 14:30 Plenary-  Chairman: Nejad Ghashti  
New technology in diagnosis of PKD (NGS):  Dr. Saeid Morovvati  
14:30 16:00 Dialysis guidelines- Chairman: Tabkhi, Mosavi Movahed Research Work shop
14:30 15:00 Dialysis adequacy and patient outcome: Aly Elkhodi​ry, Germany Scientometric Indices
15:00 15:30 How to deliver physiological dialysis for a better patient outcome: Aly Elkhodi​ry, Germany
15:15 16:00 Cardiovascular risk of Dialysis patients and volume overload: Aly Elkhodi​ry, Germany
16:00 16:20 Break
16:20 18:00 Dialysis guidelines: Chairman: Azmandian, Makhdoomi Research Work shop
16:20 16:40 Hyperlipidemia: Dr.Ahmadi, IRAN Common Errors & Publishing Tips
16:40 17:00 Vaccinations: Joneidi, IRAN
17:00 17:30 Anticoagulants: Rahimzadeh, IRAN
17:30 17:50 Prevention of intravascular catheter-related infections: Izadi, IRAN
17:50 18:00 Discussion
4 August 2016
Time HALL A HALL B
8:00 9:00 Oral presentation- Chairman: Nazemian, Soltani Oral presentation Chairman: Taybi,Tabkhi
9:00 10:30 New insights in Kidney disease by Biomarkers- Abedi Azar, Nafar Nursing Work shop (Najafi, Atabak )
9:00 9:30 Biomarkers in renal Transplantation: Nafar, IRAN
9:30 9:50 Factors affecting bioavailability of immunosuppressive drugs: Massri, Lebanon Peritoneal Dialysis
9:50 10:10 Biomarkers in IgA nephropathy: Samavat, IRAN
10:10 10:30 Biomarkers in Focal segmental Glomerulosclerosis: Kalantari, IRAN
10:30 11:00 Break
11:00 11:30 Plenary- Chairman: Razeghi, Shahidi  
Stem cell therapy: a bridge to transplantation: Marwan Masri, LEBANON  
11:30 13:00 Critical care nephrology- Chairman: Miladipour, Nasiri Nursing Work shop (Najafi, Atabak)
11:30 12:00 Fluid therapy in critically ill patients: Nasiri, IRAN Peritoneal Dialysis
12:00 12:30 Novelties in treatment Of sepsis: Darvishi, IRAN
12:30 13:00 Dialysis in critically ill patients. What matters? Shahidi, IRAN